The evolution of poly(ADP-ribose) polymerase inhibitors in the treatment of breast cancer.

Domchek, Susan M

The evolution of poly(ADP-ribose) polymerase inhibitors in the treatment of breast cancer. [electronic resource] - Clinical advances in hematology & oncology : H&O May 2018 - 330-332 p. digital

Publication Type: Journal Article

1543-0790


Animals
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
BRCA1 Protein--antagonists & inhibitors
BRCA2 Protein--antagonists & inhibitors
Breast Neoplasms--drug therapy
Capecitabine--therapeutic use
Female
Furans--therapeutic use
Gene Expression Regulation, Neoplastic
Humans
Indazoles--therapeutic use
Indoles--therapeutic use
Ketones--therapeutic use
Mutation
Phthalazines--therapeutic use
Piperazines--therapeutic use
Piperidines--therapeutic use
Poly(ADP-ribose) Polymerase Inhibitors--therapeutic use
Poly(ADP-ribose) Polymerases--genetics
Prognosis
Randomized Controlled Trials as Topic
Survival Analysis
Vinblastine--analogs & derivatives
Vinorelbine